title: Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy.
abstract: This retrospective study evaluated the safety and efficacy of using polidocanol with X-ray fluoroscopy for percutaneous sclerotherapy of venous malformations of the limbs, head, and neck. The subjects were 16 of 18 patients who presented to our department with venous malformations. Two patients were excluded because they were unlikely to benefit from the treatment. Of the 16 included in the study, 1 could not be treated because of inaccessibility, and another was lost to follow-up. Among the 14 cases that we were able to follow-up, 11 cases had had pain as their primary symptom. Following treatment, this symptom remained unchanged in 1 patient, was improved in 4, and had disappeared in 6; however, there was a recurrence of pain for 3 of these patients. Two patients had sought treatment for cosmetic purposes; following treatment, the lesion disappeared in one and showed a significant reduction in the other. The remaining patient presented with a primary symptom of mouth bleeding, which disappeared following treatment. There were no critical complications. Percutaneous sclerotherapy of venous malformations using polidocanol is safe and effective, and permits repeat treatments. The efficacy is especially good for resolving pain, and complications are minor. It is desirable to use fluoroscopy for these procedures
authors.affiliation: Department of Radiology, Okayama University Gradudate School of Medicine and Dentistry, Okayama 700-8558, Japan. h-mimura@ccmail.cc.okayama-u.ac.jp
authors.forename: Hidefumi
authors.initials: H
authors.lastname: Mimura
authors.forename: Susumu
authors.initials: S
authors.lastname: Kanazawa
authors.forename: Kotaro
authors.initials: K
authors.lastname: Yasui
authors.forename: Hiroyasu
authors.initials: H
authors.lastname: Fujiwara
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Hyodo
authors.forename: Takashi
authors.initials: T
authors.lastname: Mukai
authors.forename: Shuichi
authors.initials: S
authors.lastname: Dendo
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Iguchi
authors.forename: Takao
authors.initials: T
authors.lastname: Hiraki
authors.forename: Isao
authors.initials: I
authors.lastname: Koshima
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Hiraki
mesh_terms: D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D002560:Cerebrovascular Circulation; D002648:Child; D000013:Congenital Abnormalities / Q000503:physiopathology; D005121:Extremities / Q000098:blood supply; D005260:Female; D005471:Fluoroscopy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009333:Neck / Q000098:blood supply; D010146:Pain / Q000503:physiopathology; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000008:administration & dosage* / Q000009:adverse effects; D012189:Retrospective Studies; D012597:Sclerosing Solutions / Q000008:administration & dosage* / Q000009:adverse effects; D015911:Sclerotherapy / Q000009:adverse effects; D014680:Veins / Q000002:abnormalities*
chemical_list: D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols